Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more


pLVpuro-CMV-N-EGFP Citations (2)

Originally described in: Redundancy of human ATG4 protease isoforms in autophagy and LC3/GABARAP processing revealed in cells.
Agrotis A, Pengo N, Burden JJ, Ketteler R Autophagy. 2019 Jan 21. doi: 10.1080/15548627.2019.1569925.
PubMed Journal

Articles Citing pLVpuro-CMV-N-EGFP

CNK2 promotes cancer cell motility by mediating ARF6 activation downstream of AXL signalling. Serwe G, Kachaner D, Gagnon J, Plutoni C, Lajoie D, Durame E, Sahmi M, Garrido D, Lefrancois M, Arseneault G, Saba-El-Leil MK, Meloche S, Emery G, Therrien M. Nat Commun. 2023 Jun 15;14(1):3560. doi: 10.1038/s41467-023-39281-z. PubMed
Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Malnassy G, Keating CR, Gad S, Bridgeman B, Perera A, Hou W, Cotler SJ, Ding X, Choudhry M, Sun Z, Koleske AJ, Qiu W. Cell Mol Gastroenterol Hepatol. 2023;16(5):685-709. doi: 10.1016/j.jcmgh.2023.07.006. Epub 2023 Jul 15. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.